Sen. Crapo Submits Op-Ed on Lower Costs, More Cures Act
March 12, 2020
March 12, 2020
WASHINGTON, March 12 -- Sen. Mike Crapo, R-Idaho, issued the following op-ed on the Lower Costs, More Cures Act, published in the Wall Street Journal:
In a Wall Street Journal op-ed penned by Joe Grogan, Director of the White House Domestic Policy Council, the Administration outlined five principles for reducing drug costs while maintaining America's strength in pharmaceutical innovation. The Lower Costs, More Cures Act, introduced in the Senate on December 19, 2019, meets and excee . . .
In a Wall Street Journal op-ed penned by Joe Grogan, Director of the White House Domestic Policy Council, the Administration outlined five principles for reducing drug costs while maintaining America's strength in pharmaceutical innovation. The Lower Costs, More Cures Act, introduced in the Senate on December 19, 2019, meets and excee . . .